IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023

IAS 2023，第 12 届 IAS HIV 科学会议，澳大利亚布里斯班，虚拟会议，2023 年 7 月 23-26 日

• 批准号: 10696505
• 负责人: Christopher C. Beyrer
• 金额: $ 75万
• 依托单位: IAS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10696505
• 关键词: 2019-nCoV; AIDS prevention; Acceleration; Acquired Immunodeficiency Syndrome; Address; Affect; Antibody Response; Antiviral Agents; Area; Asia; Attention; Australia; Basic Science; Behavioral; Behavioral Sciences; COVID-19; COVID-19 impact; COVID-19 pandemic; COVID-19 pandemic effects; Caring; Clinic; Clinical; Clinical Sciences; Communities; Competence; Complex; Consensus; Country; Couples; Development; Discrimination; Disease remission; Economics; Emergency response; Ensure; Epidemic; Epidemiology; Formulation; Fostering; Geography; Goals; Guidelines; HIV; HIV Infections; HIV vaccine; Health; Health Personnel; Health system; Human; Human immunodeficiency virus test; Hybrids; Immunology; Improve Access; Incidence; Individual; Infection; Infrastructure; International; International AIDS; Intervention; Knowledge; Leadership; Life; Messenger RNA; Methods; Minority; Monkeypox; Outcome; Outcomes Research; Participant; Pathogenesis; Personal Satisfaction; Persons; Pharmaceutical Preparations; Policies; Policy Maker; Politics; Population; Populations at Risk; Prevention; Prevention Research; Prevention approach; Prevention program; Private Sector; Public Health; RNA vaccine; Research; Research Personnel; Resource-limited setting; Rights; Scholarship; Science; Scientist; Social Sciences; Stigmatization; Structure; System; Technology; Testing; Translating; Treatment outcome; Vaccines; Viral; Viral hepatitis; Work; base; civil society; co-infection; comorbidity; cost effective; design; exhibitions; experience; forging; gender diversity; gene therapy; implementation barriers; implementation research; implementation science; improved; indigenous community; innovation; insight; interdisciplinary collaboration; low and middle-income countries; marginalization; marginalized population; meetings; member; men who have sex with men; multidisciplinary; neutralizing antibody; novel; pandemic disease; pandemic preparedness; patient oriented; person centered; posters; precision medicine; prevention practice; programs; public health emergency; response; scale up; sex; social; social health determinants; social stigma; success; symposium; synergism; transmission process; uptake; vaccinology; viral pandemic; virology; virtual

Project Summary IN 2021 UNAIDS estimated the HIV incidence to have been 1.5 million new infections, while the 2020 target was set to be under 500,000 global infections for that year. At this rate, the HIV response is sharply off target to achieve the goal of an end to the pandemic as the global public health threat by 2030. The COVID-19 pandemic has severely affected the HIV response as it has caused consequential disruption in the HIV response, HIV testing and prevention. Furthermore, with WHO’s declaration of Monkeypox as a public health emergency of international concern, and this new emergence currently occurring overwhelmingly among men who have sex with men, a community with a very high burden for HIV, there are currently three concurrent pandemics underway challenging human health and wellbeing, health systems, and fragile public health infrastructures worldwide. IAS 2023 must address HIV science in the context of a wider pandemic preparedness and with a view toward the impacts of COVID-19 and Monkeypox on persons living with HIV, and on health systems and providers. Vaccine science will be prominent, as well as antiviral agents and their interactions for all three of these viral pandemics. Accelerate basic science and clinical science innovation in the development and application of person-centered precision medicine for HIV treatment, reducing HIV transmission, vaccines, pathogenesis, co-infections, and the search for a cure will feature prominently at IAS 2023. Specific aims of IAS 2023 will be to: 1. Advance inter-disciplinary collaboration in implementation research to reduce HIV transmission and improve treatment outcomes across all life-stages with a special focus on translating research outcomes into policy and practice through simplified practical guidelines for low- and middle-income countries and key populations. 2. Strengthen HIV prevention research to improve cost-effective biomedical, behavioral and structural interventions with a special focus on understanding implementation challenges, overcoming system barriers and replicating successes in HIV prevention practice and programs. 3. Address HIV vulnerability, determinants of HIV burdens and poor clinical outcomes among key and marginalized populations, including interventions to reduce stigma and discrimination and improve access and uptake of ART for prevention and treatment with a special focus on First Nations and Indigenous communities and on person-centered approaches. 4. Re-engage and reenergize community, clinical, social and political efforts to address unmet HIV needs and strengthen HIV policy in the Asia-Pacific region in the COVID-19 era, paying special attention to the needs of marginalized First Nations and Indigenous communities. The scientific program will be structured along five scientific tracks: basic science; clinical science; epidemiology & prevention science; social and behavioural sciences; implementation science, economics, systems and synergies. Topics to be addressed in each thematic area are described below. The scientific program is developed by a multi-disciplinary international Organizing Committee whose members are selected on the bases of scientific, policy and implementation expertise, meaningful engagement and representation of key and affected populations, of civil society and / or young people and geographic and gender diversity as key competencies and attributes ensuring diversity at all levels. Cross-cutting aspects will be highlighted in plenary talks that also connect the science with community and leadership perspectives. Additionally, bridging sessions are designed to cut across the different thematic areas to provide opportunities for multi-disciplinary, multi- perspective dialogues, often using interactive formats. Building on the success of the 24th International AIDS Conference - AIDS 2022 in hybrid format, IAS 2023 will be held in-person and virtually, providing many opportunities for discussions, debates and interconnection between the in-person and virtual speakers and audiences. Expected attendance is 6,000 HIV scientists, clinicians, policy makers, and program implementers as well as civil society, community and private sector representatives (4,500 in person and 1,500 online). IAS 2023 will provide scholarships to ensure the full participation of researchers, community activists and civil society representatives, especially those from resource-limited settings and underrepresented communities. Guided by best practices, the hybrid format will maximize inclusive conference experiences for all stakeholders at all levels.

项目概要 联合国艾滋病规划署估计，2021 年艾滋病毒新感染人数将达到 150 万，而 2020 年的目标是 预计当年全球感染人数将低于 50 万，按照这个速度，艾滋病毒应对工作远远偏离了目标。 实现到 2030 年消除全球公共卫生威胁这一大流行病的目标。 COVID-19 大流行严重影响了艾滋病毒应对工作，因为它造成了相应的破坏 此外，世界卫生组织宣布猴痘为公众感染。 国际关注的突发卫生事件，而这种新出现的情况目前绝大多数发生在 男男性行为者是艾滋病毒负担非常高的社区，目前有3个并发 正在发生的流行病挑战着人类健康和福祉、卫生系统以及脆弱的公共卫生 IAS 2023 必须在更广泛的大流行防范背景下解决艾滋病毒科学问题。 并着眼于 COVID-19 和猴痘对艾滋病毒感染者和健康的影响 疫苗科学以及抗病毒药物及其相互作用将占据重要地位。 所有这三种病毒大流行加速基础科学和临床科学的发展。 以人为本的精准医学在艾滋病毒治疗、减少艾滋病毒传播、疫苗、 发病机制、合并感染和治疗方法的探索将成为 2023 年 IAS 的重点内容。 IAS 2023 的具体目标是： 1. 推进实施研究中的跨学科合作，以减少艾滋病毒传播并改善 所有生命阶段的治疗结果，特别注重将研究成果转化为政策 通过针对中低收入国家和关键国家的简化实用指南进行实践和实践 人口。 2. 加强艾滋病毒预防研究，提高生物医学、行为和结构方面的成本效益 干预措施特别注重了解实施挑战、克服系统障碍 复制艾滋病毒预防实践和计划的成功经验。 3. 解决关键和关键人群中的艾滋病毒脆弱性、艾滋病毒负担的决定因素和不良临床结果 边缘化人群，包括减少耻辱和歧视并改善获得机会的干预措施 并采用抗逆转录病毒疗法进行预防和治疗，特别关注原住民和原住民 社区和以人为本的方法。 4. 重新参与社区、临床、社会和政治努力并为其注入新的活力，以解决未满足的艾滋病毒需求和 加强COVID-19时代亚太地区的艾滋病毒政策，特别关注需求 原住民和原住民社区不断减少。 该科学计划将按照五个科学轨道进行构建：基础科学；流行病学； 和预防科学；社会和行为科学；实施科学、经济学、系统和 每个专题领域要讨论的主题如下所述。 由多学科国际组委会制定，其成员是根据以下基础选出的 科学、政策和专业知识的实施、关键和关键领域的有意义的参与和代表性 受影响人群、民间社会和/或年轻人以及地理和性别多样性是关键 全体会议将确保强调各个层面的能力和属性多样性。 此外，还将科学与社区和领导力观点联系起来的讲座，以及桥接会议。 旨在跨越不同的主题领域，为多学科、多领域的研究提供机会 观点对话，通常使用互动形式。 在第 24 届国际艾滋病大会 - AIDS 2022 混合形式的成功基础上，IAS 2023 将 面对面和虚拟举行，提供许多讨论、辩论和相互联系的机会 现场和虚拟演讲者及观众预计将有 6,000 名艾滋病毒科学家参加， 维权者、政策制定者和方案实施者以及民间社会、社区和私营部门 代表（4,500 名现场代表和 1,500 名在线代表）将提供奖学金，以确保全额奖学金。 研究人员、社区活动家和民间社会代表的参与，特别是来自 在最佳实践的指导下，混合格式将适应资源有限的环境和代表性不足的社区。 最大限度地为各级所有利益相关者提供包容性会议体验。